ChengDu Sheng Nuo Biotec (688117.SH): Subsidiary signs sales contract for GLP-1 peptide active pharmaceutical ingredients worth no more than 350 million yuan.

17/09/2024

GMT Eight

ChengDu Sheng Nuo Biotec (688117.SH) announced that its wholly-owned subsidiary, ChengDu Sheng Nuo Biotec Pharmaceutical Co., Ltd. ("Sheng Nuo Pharmaceutical"), recently signed a "Product Procurement Contract" with a certain customer to supply GLP-1 peptide bulk drugs to the counterparty. The contract amount is not more than RMB 350 million (including tax).

Shenzhen King Explorer Science And Technology Corporation (002917.SZ): "JWL-HD emulsion explosive/emulsion granular ammonium oil explosive unmanned production line technology and equipment" passed the identification of scientific and technological achievements.

Truking Technology (300358.SZ) executive Lei Yu has been released on bail pending trial and has resigned from his senior management position.

Contact: contact@gmteight.com

ChengDu Sheng Nuo Biotec (688117.SH): Subsidiary signs sales contract for GLP-1 peptide active pharmaceutical ingredients worth no more than 350 million yuan.

RECOMMEND

Kezhu Real Estate: Which of the four central enterprises in the real estate industry has the upper hand?

Harris accepts CNN's invitation to participate in the second debate and calls on Trump to "fight again".

Analogy to the Chinese internet in 2020-21, HSBC states: Another new trend has emerged, Asian AI stocks hit their peak.